First human tests begin for new drug candidate
NCT ID NCT06425861
Summary
This is an early-stage study to check the safety of a new oral drug called THB335 and see how the body absorbs and processes it. It involved 60 healthy adult volunteers. The main goal was to find safe dose levels and understand the drug's basic effects in people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
QPS Miami
Miami, Florida, 33143, United States
Conditions
Explore the condition pages connected to this study.